An afternoon lecture by Join Northeastern Law‘s Center for Law, Information and Creativity (CLIC). Tuesday, April 2, 2024 | 4:30 - 6:00 PM ET | 220 Dockser Speaker: Michael Veale
Northeastern Law is pleased to announce that Erin Islo, an expert on civil procedure, arbitration, algorithmic bias and economic justice, will join the Northeastern community on July 1, 2023, as assistant professor of law. Islo’s work utilizes philosophical, legal and empirical methods to explore the rights of consumers and workers and the civil and criminal regulation of the family.
Watch now: Professor Hemanth Gundavaram, co-director of #NUSL’s Immigrant Justice Clinic, appeared on NECN’s The Take. He talked about President Donald Trump’s speech on the border wall, the impact of the government shutdown and the commitment to public interest that he sees in his students at Northeastern.
Simone Yhap ’22, the 55th National Chair of the National Black Law Students Association, is profiled by News@Northeastern. “Whenever I’m leading something or engaged in something, I ask, ‘How is this positively impacting the communities, not only that I’m a part of, but more importantly, that I’m serving?’,” says Yhap who has secured a post-graduation job as an intellectual property litigation associate at Mintz Levin.
SCOTUS justices did not commit perjury, says Professor Dan Urman, but their careful lawyerly phrasing demonstrated their stance on Roe v Wade.
“Even if vaccines were the only consideration, overriding patents alone is not enough,” Professor Brook Baker, senior policy analyst for Health GAP, tells In These Times magazine.
Northeastern Law's Community Business Clinic (CBC) has launched a legal help desk for small businesses in Lynn, Mass. Under the supervision of Professor Jared Nicholson, CBC students will field legal questions, such as those pertaining to reopening under COVID-19 guidelines, financial assistance applications and commercial leases.
In a policy brief for The People’s Vaccine, Professor Brook Baker outlines the arguments for government-led, open technology transfer and equitable access to Covid-19 vaccine production and distribution.
“Big Pharma’s unwillingness to acknowledge that the existing IP regime did not just enable innovation — it also produced artificially restricted supplies, price profiteering, and grossly inequitable distribution first of vaccines and tests and now of Covid medicines as well,” Professor Brook Baker ’76, senior policy analyst for Health GAP, tells STAT.